ILLUMINA INC (ILU.DE) Stock Fundamental Analysis
Europe - FRA:ILU - US4523271090 - Common Stock
84.52 EUR
+1.72 (+2.08%)
ILU gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 19 industry peers in the Life Sciences Tools & Services industry. ILU gets an excellent profitability rating and is at the same time showing great financial health properties. ILU has a correct valuation and a medium growth rate. These ratings would make ILU suitable for quality investing!
1. Profitability
1.1 Basic Checks
In the past year ILU was profitable.
ILU had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: ILU reported negative net income in multiple years.
In the past 5 years ILU always reported a positive cash flow from operatings.
1.2 Ratios
ILU has a better Return On Assets (20.67%) than 100.00% of its industry peers.
ILU has a Return On Equity of 55.71%. This is amongst the best in the industry. ILU outperforms 100.00% of its industry peers.
With an excellent Return On Invested Capital value of 13.42%, ILU belongs to the best of the industry, outperforming 94.74% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 20.67% | ||
| ROE | 55.71% | ||
| ROIC | 13.42% |
ROA(3y)-22.28%
ROA(5y)-10.63%
ROE(3y)-46.16%
ROE(5y)-23.48%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Profit Margin, with a value of 29.37%, ILU belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
The Operating Margin of ILU (20.59%) is better than 94.74% of its industry peers.
In the last couple of years the Operating Margin of ILU has declined.
ILU has a better Gross Margin (66.55%) than 100.00% of its industry peers.
ILU's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 20.59% | ||
| PM (TTM) | 29.37% | ||
| GM | 66.55% |
OM growth 3YN/A
OM growth 5Y-11.47%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.07%
GM growth 5Y-1.23%
2. Health
2.1 Basic Checks
ILU has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
ILU has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for ILU has been increased compared to 5 years ago.
ILU has a worse debt/assets ratio than last year.
2.2 Solvency
ILU has an Altman-Z score of 3.56. This indicates that ILU is financially healthy and has little risk of bankruptcy at the moment.
ILU's Altman-Z score of 3.56 is fine compared to the rest of the industry. ILU outperforms 68.42% of its industry peers.
The Debt to FCF ratio of ILU is 1.93, which is an excellent value as it means it would take ILU, only 1.93 years of fcf income to pay off all of its debts.
ILU has a Debt to FCF ratio of 1.93. This is amongst the best in the industry. ILU outperforms 94.74% of its industry peers.
A Debt/Equity ratio of 0.66 indicates that ILU is somewhat dependend on debt financing.
ILU has a Debt to Equity ratio of 0.66. This is comparable to the rest of the industry: ILU outperforms 52.63% of its industry peers.
Even though the debt/equity ratio score it not favorable for ILU, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.66 | ||
| Debt/FCF | 1.93 | ||
| Altman-Z | 3.56 |
ROIC/WACC1.34
WACC10.05%
2.3 Liquidity
A Current Ratio of 1.81 indicates that ILU should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.81, ILU is in the better half of the industry, outperforming 73.68% of the companies in the same industry.
ILU has a Quick Ratio of 1.41. This is a normal value and indicates that ILU is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.41, ILU belongs to the top of the industry, outperforming 84.21% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.81 | ||
| Quick Ratio | 1.41 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 352.17% over the past year.
The earnings per share for ILU have been decreasing by -17.93% on average. This is quite bad
The Revenue has decreased by -3.27% in the past year.
Measured over the past years, ILU shows a small growth in Revenue. The Revenue has been growing by 4.29% on average per year.
EPS 1Y (TTM)352.17%
EPS 3Y-25.65%
EPS 5Y-17.93%
EPS Q2Q%230.56%
Revenue 1Y (TTM)-3.27%
Revenue growth 3Y-1.15%
Revenue growth 5Y4.29%
Sales Q2Q%-4.77%
3.2 Future
ILU is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 23.70% yearly.
ILU is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.57% yearly.
EPS Next Y88.16%
EPS Next 2Y42.23%
EPS Next 3Y31.99%
EPS Next 5Y23.7%
Revenue Next Year-1.41%
Revenue Next 2Y0.66%
Revenue Next 3Y2.26%
Revenue Next 5Y3.57%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 23.88, which indicates a rather expensive current valuation of ILU.
ILU's Price/Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Earnings ratio of 27.20, ILU is valued at the same level.
The Price/Forward Earnings ratio is 20.06, which indicates a rather expensive current valuation of ILU.
Based on the Price/Forward Earnings ratio, ILU is valued a bit cheaper than 63.16% of the companies in the same industry.
ILU's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 22.71.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 23.88 | ||
| Fwd PE | 20.06 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, ILU is valued a bit cheaper than 68.42% of the companies in the same industry.
100.00% of the companies in the same industry are more expensive than ILU, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 14.83 | ||
| EV/EBITDA | 13.44 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of ILU may justify a higher PE ratio.
A more expensive valuation may be justified as ILU's earnings are expected to grow with 31.99% in the coming years.
PEG (NY)0.27
PEG (5Y)N/A
EPS Next 2Y42.23%
EPS Next 3Y31.99%
5. Dividend
5.1 Amount
No dividends for ILU!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
FRA:ILU (9/16/2025, 7:00:00 PM)
84.52
+1.72 (+2.08%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners101.51%
Inst Owner ChangeN/A
Ins Owners0.17%
Ins Owner ChangeN/A
Market Cap12.99B
Analysts72
Price Target94.81 (12.17%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8.3%
Min EPS beat(2)1.33%
Max EPS beat(2)15.27%
EPS beat(4)3
Avg EPS beat(4)8.93%
Min EPS beat(4)-7.76%
Max EPS beat(4)26.88%
EPS beat(8)6
Avg EPS beat(8)115.88%
EPS beat(12)10
Avg EPS beat(12)231.91%
EPS beat(16)13
Avg EPS beat(16)178.79%
Revenue beat(2)0
Avg Revenue beat(2)-1.08%
Min Revenue beat(2)-1.21%
Max Revenue beat(2)-0.95%
Revenue beat(4)0
Avg Revenue beat(4)-1.06%
Min Revenue beat(4)-1.91%
Max Revenue beat(4)-0.18%
Revenue beat(8)3
Avg Revenue beat(8)-0.63%
Revenue beat(12)4
Avg Revenue beat(12)-0.69%
Revenue beat(16)6
Avg Revenue beat(16)-0.56%
PT rev (1m)-4.8%
PT rev (3m)-2.29%
EPS NQ rev (1m)-0.01%
EPS NQ rev (3m)7.84%
EPS NY rev (1m)6.81%
EPS NY rev (3m)6.53%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.93%
Revenue NY rev (1m)0.72%
Revenue NY rev (3m)0.76%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 23.88 | ||
| Fwd PE | 20.06 | ||
| P/S | 3.57 | ||
| P/FCF | 14.83 | ||
| P/OCF | 13.25 | ||
| P/B | 6.77 | ||
| P/tB | 16.85 | ||
| EV/EBITDA | 13.44 |
EPS(TTM)3.54
EY4.19%
EPS(NY)4.21
Fwd EY4.98%
FCF(TTM)5.7
FCFY6.75%
OCF(TTM)6.38
OCFY7.55%
SpS23.69
BVpS12.49
TBVpS5.02
PEG (NY)0.27
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 20.67% | ||
| ROE | 55.71% | ||
| ROCE | 19.07% | ||
| ROIC | 13.42% | ||
| ROICexc | 17.89% | ||
| ROICexgc | 29.29% | ||
| OM | 20.59% | ||
| PM (TTM) | 29.37% | ||
| GM | 66.55% | ||
| FCFM | 24.07% |
ROA(3y)-22.28%
ROA(5y)-10.63%
ROE(3y)-46.16%
ROE(5y)-23.48%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-6.48%
ROICexc growth 3YN/A
ROICexc growth 5Y-9.28%
OM growth 3YN/A
OM growth 5Y-11.47%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.07%
GM growth 5Y-1.23%
F-Score6
Asset Turnover0.7
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.66 | ||
| Debt/FCF | 1.93 | ||
| Debt/EBITDA | 1.29 | ||
| Cap/Depr | 44.24% | ||
| Cap/Sales | 2.87% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 99.48% | ||
| Profit Quality | 81.96% | ||
| Current Ratio | 1.81 | ||
| Quick Ratio | 1.41 | ||
| Altman-Z | 3.56 |
F-Score6
WACC10.05%
ROIC/WACC1.34
Cap/Depr(3y)66.6%
Cap/Depr(5y)76.75%
Cap/Sales(3y)5.82%
Cap/Sales(5y)5.58%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)352.17%
EPS 3Y-25.65%
EPS 5Y-17.93%
EPS Q2Q%230.56%
EPS Next Y88.16%
EPS Next 2Y42.23%
EPS Next 3Y31.99%
EPS Next 5Y23.7%
Revenue 1Y (TTM)-3.27%
Revenue growth 3Y-1.15%
Revenue growth 5Y4.29%
Sales Q2Q%-4.77%
Revenue Next Year-1.41%
Revenue Next 2Y0.66%
Revenue Next 3Y2.26%
Revenue Next 5Y3.57%
EBIT growth 1Y265.98%
EBIT growth 3YN/A
EBIT growth 5Y-7.67%
EBIT Next Year30.52%
EBIT Next 3Y15.06%
EBIT Next 5Y14.59%
FCF growth 1Y560.27%
FCF growth 3Y28.14%
FCF growth 5Y-3.38%
OCF growth 1Y449.52%
OCF growth 3Y15.37%
OCF growth 5Y-4.45%